Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 32 most recent Form 4 transactions.
| 1,250 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 300 | $63.66 | $19.1K | -0.7% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 800 | $62.85 | $50.3K | -1.8% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,275 | $62.14 | $265.6K | -9.0% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 1,625 | $20.46 | $33.2K | +3.5% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 1,250 | $22.40 | $28K | +2.8% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 2,500 | $27.50 | $68.8K | +5.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 6,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 6,250 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 21,977 | $41.07 | $902.6K | -34.2% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 6,500 | $20.46 | $133K | +11.2% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 6,250 | $8.93 | $55.8K | +12.1% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 2,500 | $22.40 | $56K | +5.1% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL | 4,333 | $32.12 | $139.2K | -8.1% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 20,160 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT | 15,180 | — | — | +39.7% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,402 | $40.00 | $296.1K | -16.2% | Open the original filing on SEC.gov |
| Dec 15, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,910 | $36.00 | $104.8K | -6.0% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 6,250 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 67,115 | $36.00 | $2.4M | -58.0% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 6,250 | $8.93 | $55.8K | +5.7% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 12,500 | $22.40 | $280K | +12.9% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 15,000 | $27.50 | $412.5K | +18.3% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 17,500 | $26.88 | $470.4K | +27.2% | Open the original filing on SEC.gov |
| Nov 4, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $25.25 | $252.5K | +18.4% | Open the original filing on SEC.gov |